Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil PCA vs oral morphine for analgesia during burn dressing changes
2008-007322-19Phase 4Completed
- Sponsor
- Queen Victoria Hospital
- Start
- Nov 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Burn-related pain comparing Remifentanil PCA with Oral morphine (Oramorph) (2 arms). Primary endpoint: Maximum VAS pain score during dressing change. Started Nov 2010; status: completed.
02
Drugs
remifentanilmorphine
03
Conditions
Burn-related pain
Beyond the preview
Go deeper on 2008-007322-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007322-19.